These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15372088)

  • 1. Integrating pharmacogenetics into society: in search of a model.
    Webster A; Martin P; Lewis G; Smart A
    Nat Rev Genet; 2004 Sep; 5(9):663-9. PubMed ID: 15372088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using genotyping to predict responses to anti-hypertensive treatment.
    Kurland L; Lind L; Melhus H
    Trends Pharmacol Sci; 2005 Sep; 26(9):443-7. PubMed ID: 16055200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in cardiovascular antithrombotic therapy.
    Marín F; González-Conejero R; Capranzano P; Bass TA; Roldán V; Angiolillo DJ
    J Am Coll Cardiol; 2009 Sep; 54(12):1041-57. PubMed ID: 19744613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics: progress, pitfalls and clinical potential for coronary heart disease.
    Humphries SE; Hingorani A
    Vascul Pharmacol; 2006 Feb; 44(2):119-25. PubMed ID: 16359930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic conception of health: is it as radical as claimed?
    Petersen A
    Health (London); 2006 Oct; 10(4):481-500. PubMed ID: 16973682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics in heart failure: promises and challenges.
    de Boer RA; van der Harst P; van Veldhuisen DJ; van den Berg MP
    Expert Opin Pharmacother; 2009 Aug; 10(11):1713-25. PubMed ID: 19558337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examples of future drugs presented at the annual meeting of the Medical Society].
    Orn P
    Lakartidningen; 2000 Dec; 97(49):5748-9. PubMed ID: 11188030
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenetics: improving drug and dose selection.
    Bhathena A; Spear BB
    Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
    Ferraro TN; Buono RJ
    Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coming pharmacogenomics revolution: tailoring drugs to fit patients' genetic profiles.
    Noah L
    Jurimetrics; 2002; 43(1):1-28. PubMed ID: 17333591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pharmacogenetics on the development and use of antipsychotic drugs.
    Reynolds GP
    Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.